TY - JOUR
T1 - Financial conflicts of interest in biomedical research
T2 - The need to improve the system
AU - Wang, Amy T.
AU - Montori, Victor M.
AU - Murad, Mohammad Hassan
PY - 2010/11
Y1 - 2010/11
N2 - Fifty years ago, the issue of conflict of interest in biomedical research appeared in the national spotlight and has remained in a state of constant evolution. Government legislation caused a boom in collaborations between physicians, researchers, academic institutions and industry. These relationships continue to advance medical science and make meaningful progress, yet they may threaten the integrity of physicians an-d researchers and the public's trust in medicine. This article will highlight the evolution of industry relationships and conflict of interest over time, discuss methods by which industry can potentially exert effects and propose new directions for the future.
AB - Fifty years ago, the issue of conflict of interest in biomedical research appeared in the national spotlight and has remained in a state of constant evolution. Government legislation caused a boom in collaborations between physicians, researchers, academic institutions and industry. These relationships continue to advance medical science and make meaningful progress, yet they may threaten the integrity of physicians an-d researchers and the public's trust in medicine. This article will highlight the evolution of industry relationships and conflict of interest over time, discuss methods by which industry can potentially exert effects and propose new directions for the future.
UR - http://www.scopus.com/inward/record.url?scp=79952278522&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79952278522&partnerID=8YFLogxK
U2 - 10.1358/dnp.2010.23.9.1521763
DO - 10.1358/dnp.2010.23.9.1521763
M3 - Review article
C2 - 21152455
AN - SCOPUS:79952278522
SN - 0214-0934
VL - 23
SP - 607
EP - 612
JO - Drug News and Perspectives
JF - Drug News and Perspectives
IS - 9
ER -